Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators. - Wikidata - awgldk - TriplyDB

Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators.

Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators.

http://www.wikidata.org/entity/Q47877643

about

Peroxisome proliferator-activated receptors (PPARs) and ovarian function--implications for regulating steroidogenesis, differentiation, and tissue remodeling.Immunotoxicity of perfluorooctanoic acid and perfluorooctane sulfonate and the role of peroxisome proliferator-activated receptor alpha The orphan nuclear receptor ROR alpha is a negative regulator of the inflammatory response SUMOylation of human peroxisome proliferator-activated receptor alpha inhibits its trans-activity through the recruitment of the nuclear corepressor NCoR Inflammation, stress, and diabetes Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis PPARs and the cardiovascular system Impaired skin wound healing in peroxisome proliferator-activated receptor (PPAR)alpha and PPARbeta mutant mice Cannabinoid activation of PPAR alpha; a novel neuroprotective mechanism Transcriptional regulation of lipid metabolism by fatty acids: a key determinant of pancreatic beta-cell function Different effects of antisense RelA p65 and NF-kappaB1 p50 oligonucleotides on the nuclear factor-kappaB mediated expression of ICAM-1 in human coronary endothelial and smooth muscle cells Cytochrome P450 ω-Hydroxylases in Inflammation and Cancer Vascular targets for cannabinoids: animal and human studies Regulation of Ketone Body Metabolism and the Role of PPARα Peroxisome proliferator-activated receptors in cutaneous biology Fenofibrate: a novel formulation (Triglide) in the treatment of lipid disorders: a review Suppression of inducible cyclooxygenase 2 gene transcription by aspirin and sodium salicylate Inhibition by troglitazone of the antigen-induced production of leukotrienes in immunoglobulin E-sensitized RBL-2H3 cells Oxidized low-density lipoprotein and peroxisome-proliferator-activated receptor alpha down-regulate platelet-activating-factor receptor expression in human macrophages Statin-induced inhibition of the Rho-signaling pathway activates PPARalpha and induces HDL apoA-I Peroxisome proliferator-activated receptor beta regulates acyl-CoA synthetase 2 in reaggregated rat brain cell cultures Adaptive cellular stress pathways as therapeutic targets of dietary phytochemicals: focus on the nervous system Anticancer effects of 15d-prostaglandin-J2 in wild-type and doxorubicin-resistant ovarian cancer cells: novel actions on SIRT1 and HDAC The PPARdelta agonist GW501516 suppresses interleukin-6-mediated hepatocyte acute phase reaction via STAT3 inhibition Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARdelta Bifidobacteria can protect from enteropathogenic infection through production of acetate The nuances of atherogenic dyslipidemia in diabetes: focus on triglycerides and current management strategies.PPAR alpha inhibits vascular smooth muscle cell proliferation underlying intimal hyperplasia by inducing the tumor suppressor p16INK4a.15-Deoxy-Delta(12,14)-prostaglandin J(2) facilitates thyroglobulin production by cultured human thyrocytes.PPARalpha deficiency in inflammatory cells suppresses tumor growth.Effects of gemfibrozil on outcome after permanent middle cerebral artery occlusion in mice Fenofibrate improves cerebral blood flow after middle cerebral artery occlusion in mice.The peroxisome proliferator-activated receptor-alpha (PPAR-alpha) agonist, AVE8134, attenuates the progression of heart failure and increases survival in rats.Nitro-oleic acid downregulates lipoprotein-associated phospholipase A2 expression via the p42/p44 MAPK and NFκB pathways High-fat diet reduces local myostatin-1 paralog expression and alters skeletal muscle lipid content in rainbow trout, Oncorhynchus mykiss.Rescue of glucocorticoid-programmed adipocyte inflammation by omega-3 fatty acid supplementation in the rat.Reduction of circulating cholesterol and apolipoprotein levels during sepsis.Is spaceflight-induced immune dysfunction linked to systemic changes in metabolism?Multifaceted Mechanisms of WY-14643 to Stabilize the Blood-Brain Barrier in a Model of Traumatic Brain Injury Fenofibrate reduces systemic inflammation markers independent of its effects on lipid and glucose metabolism in patients with the metabolic syndrome

P2860

Q21245560-AB2E73D1-4E01-4B89-8210-1890835F2D68 Q23914416-BF8FFD01-56A3-476C-AA86-A4E97E927F14 Q24290927-FA90A1E5-50ED-4322-A045-57B14E0C3413 Q24324236-8065CD3B-9054-4EA8-9E28-88914A67B7D7 Q24523336-05868200-E517-4B8D-A311-2C99EBBEFD30 Q24541529-8B44F829-EBED-46FA-A71E-54D8CBF374B9 Q24642728-9689B4CC-16E9-44ED-A2F7-33560F7141AC Q24669591-A4683129-6007-49B1-9E21-2EDFB955C13A Q24681426-794AB365-23BC-4D32-9E5D-BC67E7C3C79F Q24803245-E8A410FE-CA28-499E-A4FF-9ED9BEBA1DD2 Q24803331-2B06ACCD-BEFF-4633-806A-538B6F18021E Q26800210-EC9DD047-548A-4F00-A950-EE1957BEDCE8 Q26862515-1CC7729D-332A-4416-80D3-5EC496A763C9 Q28073224-4B16378D-91B8-45D3-A54A-76BF4A07C84E Q28202926-5595CDED-65BA-4637-BB35-BBE347B2A61D Q28220294-F9B7EC4E-74BF-44D7-8B02-8B89A5885C5F Q28343291-0E47552C-FEAB-4502-B913-7148ADC2E5D0 Q28343969-E81859A5-27AC-4B04-8406-2EAB5CE61F16 Q28348220-9196328C-2621-4722-AD18-45BE104C54AC Q28366335-74A23F00-5B00-4101-8F92-AE7D23A323CE Q28377342-BFAC2B07-A6EC-4F6F-81F4-89259DA74A7D Q28389419-DF6F97C3-B987-49F1-969A-4BCD51235701 Q28477173-3E98FC26-AA26-4296-8669-BDFFF7707AFC Q28572346-248C8822-29FB-4CD3-B647-0C0BD68ACB85 Q28587698-00B493BF-2567-402D-9E12-035EFF1B6702 Q29617592-143CAAE4-25E9-4582-880E-5CC23ADAA6F4 Q30357715-B20705E0-44BE-451A-BA95-447D128CE94F Q30476274-83F45E79-2FC1-4F2E-BB8D-23374819873F Q31566836-897ECB89-96FA-41C5-898B-A355F68F051A Q33275971-B2CBADC0-A242-4417-9D76-5770D5A62AE8 Q33442332-5E88658B-CC64-4EF9-BDE6-4ECC3A40478F Q33499205-6632D9F3-47FF-4019-9B99-16ABB4FAA330 Q33552642-B0BB5817-D23E-4FE5-A88C-9C4AFDDFEB16 Q33585468-DF2972E5-4D98-491A-AFD8-D94C0E429D98 Q33591060-56FFD072-DE53-495D-9E3F-C652B0E23ED6 Q33617646-67F295DF-582A-4938-9DAE-C37CA1969375 Q33649891-76ED7BCD-4552-4F13-A99D-DF5B82230759 Q33724786-23DC4089-9A73-424D-94E5-0CABCB94ED38 Q33729415-A78E14A8-74EC-41E8-AE8C-D39037DB877A Q33736139-4FC85153-26C0-4E0C-9317-349EBDBFD095

P2860

Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators.

http://www.wikidata.org/entity/Q47877643

description

1998 nî lūn-bûn

@nan

1998年の論文

@ja

1998年学术文章

@wuu

1998年学术文章

@zh

1998年学术文章

@zh-cn

1998年学术文章

@zh-hans

1998年学术文章

@zh-my

1998年学术文章

@zh-sg

1998年學術文章

@yue

1998年學術文章

@zh-hant

name

Activation of human aortic smo ...... t not by PPARgamma activators.

@en

Activation of human aortic smo ...... t not by PPARgamma activators.

@nl

type

label

Activation of human aortic smo ...... t not by PPARgamma activators.

@en

Activation of human aortic smo ...... t not by PPARgamma activators.

@nl

prefLabel

Activation of human aortic smo ...... t not by PPARgamma activators.

@en

Activation of human aortic smo ...... t not by PPARgamma activators.

@nl

P1433

Q47877643-842EA80A-6CB5-4AA7-849D-EDB7A77B0035

P1476

Q47877643-063A290D-805D-4D53-89CB-C5D2E09ACF80

P2093

Q47877643-10C11F27-6091-4C3B-A383-281BAE3C9E0D

Q47877643-27714496-37F5-451D-82E6-303EC28E011F

Q47877643-3868C4AA-D690-4D4D-9005-0B3A675C98DD

Q47877643-476AA8BF-E077-4DD5-B862-E463E68F8762

Q47877643-5523F90A-0563-48DB-8AAF-95878DB8580D

Q47877643-5706F69A-8FC4-4604-90FA-9829F9D9FADA

Q47877643-5C9A26A9-BC33-49D4-B0C0-9187E1484ADA

Q47877643-E6040900-C173-4093-BE7C-4928739F8356

Q47877643-F0259D6E-3517-40E0-A6AC-4BCD6A7340EE

P2888

Q47877643-46F8688D-79EE-4B5C-BC89-E354FE27CD41

P304

Q47877643-2D462692-8E70-4AF7-9BB8-6D14CC501BBB

P31

Q47877643-1C266B9F-85C9-4D2E-9C70-C25806A0C8EC

P356

Q47877643-B890AF09-5365-47A3-9EDD-D9C4E53A448D

P407

Q47877643-DD401884-2AB0-43F4-B863-F9198B508CD1

P433

Q47877643-490B71B2-D8A6-4EFC-81AA-D2B9CB51674B

P478

Q47877643-65CAE5DC-8D66-42CB-B134-FDCC04B2B69A

P50

Q47877643-04468011-C363-445B-BA9E-22E88B0E3A7C

Q47877643-193399E3-4B61-4A03-96ED-B54BF83FFEC5

Q47877643-95AC0309-11F3-4AE8-800C-E486C5E79BDC

Q47877643-BF5F24A4-361C-44BC-BB3E-4688CA76E328

P577

Q47877643-1E4340E1-7EB2-43DC-90EE-CF9BB270EF8B

P6179

Q47877643-C8FBC779-9743-415D-A199-C89444FF38FE

P698

Q47877643-6397078B-73DD-4E77-A343-F275D0E73C2C

P356

P1433

P1476

Activation of human aortic smo ...... t not by PPARgamma activators.

@en

P2093

Delerive P

http://www.w3.org/2001/XMLSchema#string

Fadel A

http://www.w3.org/2001/XMLSchema#string

Fruchart JC

http://www.w3.org/2001/XMLSchema#string

Lebret M

http://www.w3.org/2001/XMLSchema#string

Maclouf J

http://www.w3.org/2001/XMLSchema#string

Merval R

http://www.w3.org/2001/XMLSchema#string

Najib J

http://www.w3.org/2001/XMLSchema#string

Tedgui A

http://www.w3.org/2001/XMLSchema#string

Torra IP

http://www.w3.org/2001/XMLSchema#string

P2888

P304

790-793

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/31701

http://www.w3.org/2001/XMLSchema#string

P407

P433

6687

http://www.w3.org/2001/XMLSchema#string

P478

393

http://www.w3.org/2001/XMLSchema#string

P50

Wolfgang Koenig

Giulia Chinetti

P577

1998-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1040460300

http://www.w3.org/2001/XMLSchema#string

P698

9655393

http://www.w3.org/2001/XMLSchema#string